Genetic tests tag

blog

Insurance after the genetic testing moratorium?

John Chevers

Since 2001 there has been a voluntary moratorium in the UK precluding the use of genetic information for insurance purposes, except in specific circumstances.

blog

The challenges posed by direct-to-consumer genetic tests

Mark Kroese

blog

The benefits and harms of breast cancer screening

Hilary Burton

blog

Inequities may widen for inherited cardiovascular disease

Philippa Brice

blog

Whole Genome Sequencing: Savile Row or Marks & Spencer?

Ron Zimmern

blog

AAP guidelines on genetic testing of children: a commentary

Alison Hall

blog

ACMG issues clarification over incidental findings guidance

Ron Zimmern

blog

Will Genomics England deliver a genomics revolution for health?

Philippa Brice

blog

New UK standards for familial hypercholesterolaemia

Philippa Brice

blog

Harmful cystic fibrosis mutations mapped

Philippa Brice

blog

What's the point of genetic testing for FH?

blog

Regulating genetic tests: lessons from 23andMe

Mark Kroese

blog

China imposes restrictive regulation of genetic testing

Ron Zimmern

blog

MERS-CoV outbreak: infectious disease genomics in action

Leila Luheshi

blog

Weighing the benefits of expanded newborn screening

Philippa Brice

blog

Improving diagnosis and care for inherited heart conditions

Philippa Brice

blog

23andMe engages with the FDA on health-related genetic tests

Philippa Brice

blog

China approves non-invasive prenatal tests from BGI

Philippa Brice

blog

We need to talk about genomics: delivering a legacy for the NHS

Lucia von Bredow

blog

A new risk-based approach for genetic test regulation in the US

Philippa Brice

blog

Future-proofing UK diagnostic capacity for stratified medicine

Philippa Brice

blog

Implications for BRCA testing as Australian court upholds gene patents

Philippa Brice

blog

The changing landscape of personalised cancer medicine

Philippa Brice

blog

Genomic data: to share is to care

Sobia Raza

blog

Array CGH testing for learning disability - when is it worth it?

Gurdeep Sagoo

blog

UK public at odds with health profession on genetic testing of children

Philippa Brice

blog

US clarifies position on secondary findings in clinical genome sequencing

Alison Hall

blog

Genomic sequencing study boosts rare disease diagnosis

Philippa Brice

blog

Genomics as a game-changer in public health

Charlotte Warren-Gash

blog

The shifting sands of direct-to-consumer genetic test regulation

Philippa Brice

blog

Pathology and patient perspectives for clinical genomics policy

Tom Finnegan

blog

Welcome UK moves to revolutionise uptake of innovations in healthcare

Philippa Brice

blog

NIPT for Down’s syndrome – what new evidence means for the UK

Mark Kroese

blog

Using genomics in complex diseases: do health professionals need new skills?

Susmita Chowdhury

consultation response

Revision of Directive 98/79 of the European Parliament and of the Council of 27 October 1998 on In Vitro Diagnostic Medical Devices - Response from the PHG Foundation

consultation response

A Common Framework of Principles for direct-to-consumer genetic testing services

consultation response

Genetic testing and common disorders

consultation response

Good Practice Guide in Paternity Testing Services

consultation response

Code of Practice for Genetic Tests

case study

Science into health

report

Genetics and health - Nuffield Trust Genetics Scenario Project report

report

Enhanced Genetic Services Project

PHG Foundation were commissioned to evaluate this pilot genetic services project in Birmingham..

report

Learning disability: the interface with genetics

report

Assessment of the Human Tissue Act

report

Moving Beyond ACCE: An Expanded Framework for Genetic Test Evaluation

report

Family history as a risk factor for common, complex disease

report

The evaluation of clinical validity and clinical utility of genetic tests

report

Evidence and evaluation: Building public trust in genetic tests for common diseases

report

The evaluation of diagnostic laboratory tests and complex biomarkers

report

Annual Review 2007-2008

report

Genetic ophthalmology in focus

report

Tay Sachs Disease carrier screening in the Ashkenazi Jewish population

report

Annual Review 2009

report

Expanded newborn screening

Probable benefits, harms and costs of expanding newborn screening

report

Quality standards in risk prediction

report

Stratified Screening for Cancer

blog

Ending a diagnostic odyssey

Hilary Burton

blog

Illumina reaches for the cancer testing GRAIL

Laura Blackburn

report

Whole genome sequencing for breast cancer risk testing

Examining the impact of routine testing using whole genome sequencing

report

Genetic screening programmes: an international review of assessment criteria